US Patent 8029791 Modified chimeric polypeptides with improved pharmacokinetic properties
Patent 8029791 was granted and assigned to Regeneron Pharmaceuticals, Inc. on October, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8029791 Modified chimeric polypeptides with improved pharmacokinetic properties
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
